143 related articles for article (PubMed ID: 8304928)
21. [Retinoid metabolism and cancer].
Parisotto M; Brodeur H; Bhat PV; Mader S
Med Sci (Paris); 2006 Dec; 22(12):1101-6. PubMed ID: 17156733
[TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms of chemoprevention and therapy of cancer by retinoids.
Shen PF
Front Biosci; 2004 Sep; 9():2663-70. PubMed ID: 15358589
[TBL] [Abstract][Full Text] [Related]
23. Suppression of squamous cell carcinoma growth and differentiation by retinoids.
Lotan R
Cancer Res; 1994 Apr; 54(7 Suppl):1987s-1990s. PubMed ID: 8137325
[TBL] [Abstract][Full Text] [Related]
24. Cyclin proteolysis as a retinoid cancer prevention mechanism.
Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
[TBL] [Abstract][Full Text] [Related]
25. NTP Comparative Initiation/Promotion Skin Paint Studies of B6C3F1 Mice, Swiss (CD-1(R)) Mice, and SENCAR Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Feb; 441():1-201. PubMed ID: 12595922
[TBL] [Abstract][Full Text] [Related]
26. beta-Carotene fails to act as a tumor promoter, induces RAR expression, and prevents carcinoma formation in a two-stage model of skin carcinogenesis in male Sencar mice.
Ponnamperuma RM; Shimizu Y; Kirchhof SM; De Luca LM
Nutr Cancer; 2000; 37(1):82-8. PubMed ID: 10965524
[TBL] [Abstract][Full Text] [Related]
27. Retinoids and cancer prevention.
Hill DL; Grubbs CJ
Annu Rev Nutr; 1992; 12():161-81. PubMed ID: 1503802
[TBL] [Abstract][Full Text] [Related]
28. Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion.
Tennenbaum T; Lowry D; Darwiche N; Morgan DL; Gartsbein M; Hansen L; De Luca LM; Hennings H; Yuspa SH
Cancer Res; 1998 Apr; 58(7):1435-43. PubMed ID: 9537245
[TBL] [Abstract][Full Text] [Related]
29. Retinol and beta-carotene concentrations in skin, papillomas and carcinomas, liver, and serum of mice fed retinoic acid or beta-carotene to suppress skin tumor formation.
Jones CS; Sly L; Chen LC; Ben T; Brugh-Collins M; Lichti U; De Luca LM
Nutr Cancer; 1994; 21(1):83-93. PubMed ID: 7910392
[TBL] [Abstract][Full Text] [Related]
30. Protection against 12-O-tetradecanoylphorbol-13-acetate induced skin-hyperplasia and tumor promotion, in a two-stage carcinogenesis mouse model, by the 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-[2,3-b]quinoxaline analogue of ellipticine.
Skarin T; Rozell BL; Bergman J; Toftgård R; Möller L
Chem Biol Interact; 1999 Sep; 122(2):89-106. PubMed ID: 10528995
[TBL] [Abstract][Full Text] [Related]
31. A PMLRARA transgene results in a retinoid-deficient phenotype associated with enhanced susceptibility to skin tumorigenesis.
Hansen LA; Brown D; Virador V; Tanaka T; Andreola F; Strain K; Dancheck B; Riley R; Arbeit JM; De Luca LM; Kogan S; Yuspa SH
Cancer Res; 2003 Sep; 63(17):5257-65. PubMed ID: 14500356
[TBL] [Abstract][Full Text] [Related]
32. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Mehta RG; Williamson E; Patel MK; Koeffler HP
J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of Ocimum sanctum on 3-methylcholanthrene, 7,12-dimethylbenz(a)anthracene and aflatoxin B1 induced skin tumorigenesis in mice.
Rastogi S; Shukla Y; Paul BN; Chowdhuri DK; Khanna SK; Das M
Toxicol Appl Pharmacol; 2007 Nov; 224(3):228-40. PubMed ID: 17669454
[TBL] [Abstract][Full Text] [Related]
34. Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidin B5-3'-gallate as the most effective antioxidant constituent.
Zhao J; Wang J; Chen Y; Agarwal R
Carcinogenesis; 1999 Sep; 20(9):1737-45. PubMed ID: 10469619
[TBL] [Abstract][Full Text] [Related]
35. Lack of effect of retinoic acid and fluocinolone acetonide on mirex tumor promotion indicates a novel mirex mechanism.
Kim TW; Smart RC
Carcinogenesis; 1995 Sep; 16(9):2199-204. PubMed ID: 7554075
[TBL] [Abstract][Full Text] [Related]
36. Renaissance of the biologically active vitamin A derivatives: established and novel directed therapies for cancer and chemoprevention.
Brtko J; Thalhamer J
Curr Pharm Des; 2003; 9(25):2067-77. PubMed ID: 14529416
[TBL] [Abstract][Full Text] [Related]
37. Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects.
Tratnjek L; Jeruc J; Romih R; Zupančič D
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805295
[TBL] [Abstract][Full Text] [Related]
38. Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen.
Darro F; Cahen P; Vianna A; Decaestecker C; Nogaret JM; Leblond B; Chaboteaux C; Ramos C; Pétein M; Budel V; Schoofs A; Pourrias B; Kiss R
Breast Cancer Res Treat; 1998 Sep; 51(1):39-55. PubMed ID: 9877028
[TBL] [Abstract][Full Text] [Related]
39. All-trans retinoic acid protects against conversion of chemically induced and ultraviolet B radiation-induced skin papillomas to carcinomas.
Athar M; Agarwal R; Wang ZY; Lloyd JR; Bickers DR; Mukhtar H
Carcinogenesis; 1991 Dec; 12(12):2325-9. PubMed ID: 1747935
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of phorbol ester-induced tumor promotion in mice by vitamin A analog and anti-inflammatory steroid.
Weeks CE; Slaga TJ; Hennings H; Gleason GL; Bracken WM
J Natl Cancer Inst; 1979 Aug; 63(2):401-6. PubMed ID: 110970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
